The Fox in the Henhouse: Chip Fichtner, Fear, and Greed

Bob Speil and Nate Williams open with the starfish principle—one doctor who doesn’t sell is worth the whole podcast—then analogize DSO dealmaking to Big Tobacco: a fortune in getting people hooked, almost nothing in talking them out of it. They take a highlighter to Chip Fichtner’s LPS 2025 scorecard and “just reconnect” emails, knocking the 6.75–11x EBITDA headlines down to work-backs, minority equity, and a commission machine now waving BlackRock, yachts, recruiting teams, and AI as reasons to hand over the name on the door. The closer is the real question under the sales copy: when private equity and family offices own the cash flow, who still owns the patient’s care—and why the honest answer still starts with just saying no.